European Journal of Cancer
Volume 36, Issue 16 , Pages 2090-2095, October 2000

The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT)

  • K Münstedt

      Affiliations

    • Department of Obstetrics and Gynecology, Philipps-University Marburg, Pilgrimstein 3, 35033 Marburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-6421-2864422; fax: +49-6421-2864419
  • ,
  • A Entezami

      Affiliations

    • Justus-Liebig-University Giessen, Rudolf-Buchheim-Strasse 8, 35392 Giessen, Germany
  • ,
  • A Wartenberg

      Affiliations

    • Pascoe Pharmazeutische Präparate GmbH, Schiffenberger Weg 55, 35394 Giessen, Germany
  • ,
  • U Kullmer

      Affiliations

    • Kreiskrankenhaus Giessen, Goethestrasse 4, 35423 Lich, Germany

Received 1 February 2000; received in revised form 15 May 2000; accepted 29 June 2000.

Abstract 

Physicians represent the main providers of unconventional cancer therapies (UCT) in Germany. However, little is known about providers’ characteristics, as well as their attitudes towards UCT. 833 questionnaires on this topic answered by general practitioners and hospital physicians were analysed. Providers differed significantly from non-providers with respect to gender (male>female, i.e. more male providers), age (older>younger), amount of subjective knowledge about UCT, place of work (office>hospital>university clinic), greater wish for coverage of UCT costs, the belief in future positive trends concerning UCT, the recognition of patients’ demand for UCT, the number of patients seen per month and medical specialty (GPs>oncologists and radiation oncologists). UCT were not considered to be highly effective, but estimations varied considerably. Further investigations in this area, better education about UCT, training in coping strategies with the fate of cancer patients, and reasonable complementary treatments appear to be of the utmost importance.

Keywords:  Unconventional cancer therapy, Physicians’ attitudes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(00)00194-5

European Journal of Cancer
Volume 36, Issue 16 , Pages 2090-2095, October 2000